Abbott Laboratories Kicks Off Bond Sale for Exact Sciences Deal
Abbott Laboratories is selling corporate bonds in as many as eight parts to help fund its around $21 billion acquisition of cancer-screening company Exact Sciences Corp....
Redirecting to full article...